Literature DB >> 1569399

Sequences in both class II major histocompatibility complex alpha and beta chains contribute to the binding of the superantigen toxic shock syndrome toxin 1.

N S Braunstein1, D A Weber, X C Wang, E O Long, D Karp.   

Abstract

Class II major histocompatibility complex (MHC) molecules present peptides derived from processed antigen to antigen-specific CD4-positive T cells. In addition, class II molecules bind with high affinity another class of antigens, termed superantigens. T cell stimulation by superantigens depends almost exclusively on the V beta segment expressed by the T cell receptor (TCR). Mapping of the superantigen binding site on class II molecules should provide valuable information on how MHC and TCR molecules interact. Recombinant mouse I-A class II molecules expressed on transfected L cells were analyzed for their ability to bind the toxic shock syndrome toxin 1. Polymorphic residues in the alpha helices of both the alpha and beta chains of I-A contributed to quantitative toxin binding, suggesting that the toxin binds to either a combinatorial or a conformational site on class II MHC molecules.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1569399      PMCID: PMC2119222          DOI: 10.1084/jem.175.5.1301

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  23 in total

1.  Structurally interdependent and independent regions of allelic polymorphism in class II MHC molecules. Implications for Ia function and evolution.

Authors:  N S Braunstein; R N Germain; K Loney; N Berkowitz
Journal:  J Immunol       Date:  1990-09-15       Impact factor: 5.422

2.  Staphylococcal toxins bind to different sites on HLA-DR.

Authors:  M M Chintagumpala; J A Mollick; R R Rich
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

3.  The alpha 1 domain of the HLA-DR molecule is essential for high-affinity binding of the toxic shock syndrome toxin-1.

Authors:  D R Karp; C L Teletski; P Scholl; R Geha; E O Long
Journal:  Nature       Date:  1990-08-02       Impact factor: 49.962

4.  Structural basis for differential binding of staphylococcal enterotoxin A and toxic shock syndrome toxin 1 to class II major histocompatibility molecules.

Authors:  C H Pontzer; J K Russell; H M Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

5.  Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens.

Authors:  V T Oi; P P Jones; J W Goding; L A Herzenberg; L A Herzenberg
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

6.  Superantigens interact with MHC class II molecules outside of the antigen groove.

Authors:  P Dellabona; J Peccoud; J Kappler; P Marrack; C Benoist; D Mathis
Journal:  Cell       Date:  1990-09-21       Impact factor: 41.582

7.  Binding of toxic shock syndrome toxin-1 to murine major histocompatibility complex class II molecules.

Authors:  P R Scholl; R P Sekaly; A Diez; L H Glimcher; R S Geha
Journal:  Eur J Immunol       Date:  1990-09       Impact factor: 5.532

8.  Identification of the staphylococcal enterotoxin A superantigen binding site in the beta 1 domain of the human histocompatibility antigen HLA-DR.

Authors:  A Herman; N Labrecque; J Thibodeau; P Marrack; J W Kappler; R P Sekaly
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

9.  HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells.

Authors:  A Herman; G Croteau; R P Sekaly; J Kappler; P Marrack
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

10.  Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E.

Authors:  D R Karp; E O Long
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

View more
  7 in total

1.  Distinct binding sites on HLA-DR for invariant chain and staphylococcal enterotoxins.

Authors:  D R Karp; R N Jenkins; E O Long
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

Review 2.  The potential role of superantigens in inflammatory bowel disease.

Authors:  R A Kay
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

Review 3.  Evidence for a superantigen in the pathogenesis of tuberculosis.

Authors:  J D Ohmen; R L Modlin
Journal:  Springer Semin Immunopathol       Date:  1996

Review 4.  Bacterial pyrogenic exotoxins as superantigens.

Authors:  M Kotb
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

5.  Predicted complementarity determining regions of the T cell antigen receptor determine antigen specificity.

Authors:  C D Katayama; F J Eidelman; A Duncan; F Hooshmand; S M Hedrick
Journal:  EMBO J       Date:  1995-03-01       Impact factor: 11.598

Review 6.  Staphylococcal enterotoxins.

Authors:  Irina V Pinchuk; Ellen J Beswick; Victor E Reyes
Journal:  Toxins (Basel)       Date:  2010-08-18       Impact factor: 4.546

7.  Identification of HLA-DR alpha chain residues critical for binding of the toxic shock syndrome toxin superantigen.

Authors:  P Panina-Bordignon; X T Fu; A Lanzavecchia; R W Karr
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.